Seminars in Arthritis and Rheumatism

Article	Citations
Immunogenicity of Rituximab biosimilar GP2013 in chronic inflammatory rheumatic disorders in daily clinical practice	124
Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritis	85
Looking at Fibromyalgia differently – the meaning and consequences of fibromyalgia as a dimensional disorder	72
Response letter to the editor	72
Letter to the editor regarding Outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: A meta-analysis and systematic review	70
mRNA vaccines in the rheumatologist's future	66
Hydroxyquinone use does not increase the risk of venous thromboembolism in rheumatoid arthritis patients—Real-world evidence from a population-based cohort study	63
OMERACT Filter 2.1 instrument selection for physical function domain in psoriatic arthritis: Provisional endorsement for HAQ-DI and SF-36 PF	63
Risk prediction models for incident systemic lupus erythematosus among women in the Nurses’ health study cohorts using genetics, family history, and lifestyle and environmental factors	58
Development of a patient-centered core domain set for prospective observational longitudinal outcome studies in rheumatoid arthritis: an OMERACT initiative	50
OMERACT validation of a deep learning algorithm for automated absolute quantification of knee joint effusion versus manual semi-quantitative assessment	49
Performance of cut-offs of the ASAS Health Index to discriminate between treatment groups in patients with axial spondyloarthritis in the TICOSPA trial	47
Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort	47
Combotherapies in immune-mediated inflammatory diseases: A study using the Clinical Data Warehouse from Paris Hospitals’ Public Assistance	46
Corrigendum to “Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice” [Seminars in Arthritis and Rheumatism 71 (2025) 152640]	45
Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis	40
Survival of adults with rheumatoid arthritis associated interstitial lung disease - A systematic review and meta-analysis	35
Quantification of coronary artery calcification in systemic sclerosis using visual ordinal and deep learning scoring: Association with systemic sclerosis clinical features	35
OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments	35
Hidden in plain sight: Is there a crucial role for enthesitis assessment in the treatment and monitoring of axial spondyloarthritis?	35
Expanding the Role of Mycophenolic Acid in Pediatric Lupus Nephritis: A Holistic Approach to Extrarenal Findings, Side Effects, and Long-Term Outcomes	34
Disease characteristics, co-morbidities and treatment response in a contemporary axial spondyloarthritis cohort: Analysis of 717 patients from the Greek AxSpA registry	33
Interstitial lung disease phenotype in mixed, differentiated, or overlapping, connective tissue diseases: Comment on the article by Boleto et al.	32
Are there causal mucosal drivers in the preclinical development of rheumatoid arthritis?	32
A population-based analysis of rheumatology care patterns for inflammatory arthritis during COVID-19 in Alberta, Canada	31

Raynaud's phenomenon secondary to central nervous system stimulants: A therapeutic role of α-1 adrenergic blockers?	30
Giant cell arteritis associated with scalp, tongue or lip necrosis: A French multicenter case control study	29
Assessing domain match and feasibility of candidate instruments matching with OMERACT endorsed domains to measure flare in knee and hip osteoarthritis	29
Imaging to predict early relapses after treatment discontinuation in patients with large vessel giant cell arteritis – A cohort study	27
Corrigendum to “The Glucocorticoid Toxicity Index: Measuring Change in Glucocorticoid Toxicity Over Time” [Seminars in Arthritis and Rheumatism 55 (2022):152010]	25
Using patient reported outcomes measurement information system (PROMIS®) measures in rheumatoid arthritis clinical care, research, and trials	25
Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial	25
Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritis	25
Response letter to the Editor	24
Response to: Comment to “Vitamin D in psoriatic arthritis—A systematic review and meta-analysis”	23
The clinical features of juvenile dermatomyositis: A single-centre inception cohort	23
Prevalence of crystal deposits in asymptomatic hyperuricemia according to different scanning definitions: A comparative study	23
A randomized controlled trial evaluating the effects of social networking on chronic disease management in rheumatoid arthritis	23
Risk factors for invasive fungal infections in patients with connective tissue disease: Systematic review and meta-analysis	22
Methotrexate treatment in hand osteoarthritis refractory to usual treatments: A randomised, double-blind, placebo-controlled trial	22
Therapeutic approach to central nervous system involvement of Behçet's disease	22
Systematic review of colchicine neuromyopathy: Risk factors, duration and resolution	22
The ASAS-OMERACT core domain set for axial spondyloarthritis	22
Causal association of diet-derived circulating antioxidants with the risk of rheumatoid arthritis: A Mendelian randomization study	22
Response to commentary on IgG4-related uveitis. A French cohort and literature review	22
Psychological stress in rheumatoid arthritis: a systematic scoping review	22
HRCT imaging of pulmonary involvement in granulomatosis with polyangiitis and microscopic polyangiitis at disease onset and during follow-up	21
Sarcoidosis incidence after mTOR inhibitor treatment	21
Is there a role for Pneumocystis jiroveci pneumonia prophylaxis in giant cell arteritis or polymyalgia rheumatica?	21
Defining a personalized treatment approach to rheumatoid arthritis: Using genetic markers of TNFi response	21
The autoimmune rheumatological presentation of Common Variable Immunodeficiency Disorders with an overview of genetic testing	20
Response: Early referral of patients with suspected polymyalgia rheumatica: An active involvement of the out-of-hospital public rheumatologist is needed. Reply letter to Ciro Manzo (letter to the edit	20
Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients	20
Effect of zoledronic acid with or without methylprednisolone on 3D bone area and bone shape in patients with symptomatic knee osteoarthritis: A post-hoc analysis of the ZAP2 trial	20
Effects of exercise-based interventions on inflammatory markers in patients with fibromyalgia: A systematic review and meta-analysis	19
The control group matters: Pain, physical function and strength improvements relative to the comparator intervention in knee and hip osteoarthritis	19
Women with Rheumatoid Arthritis have similar rates of postpartum maternal outcomes compared to women without autoimmune disease	19
Multiple morbidities are associated with serious infections in patients with rheumatoid arthritis	19
Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofaciti	19
Improvement of bone mineral density and new vertebral fractures during 8 years of TNF-α inhibition in patients with axial spondyloarthritis	19
Biologics in peripheral ulcerative keratitis	18
Comparative effectiveness of exercise programs for psychological well-being in knee osteoarthritis: A systematic review and network meta-analysis	18
Advances in Targeted Therapies (ATT) What's cooking in the academic's kitchen? 3TR (IMI)	18
Synovial fibroblasts in juvenile idiopathic arthritis: A scoping review	18
Small intestinal biopsy findings consistent with celiac disease in patients with idiopathic inflammatory myopathy: Review of existing literature	18
The Role of Myositis-Specific Autoantibodies and the Management of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: A Systematic Review	18
Male rheumatoid arthritis patients at substantially higher risk for cardiovascular mortality in comparison to women	18
Juvenile and adult-onset scleroderma: Different clinical phenotypes	18
Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach	18
Monoclonal antibody and anti-cytokine biologics for Kawasaki disease: A systematic review and meta-analysis	18
Looking at fibromyalgia differently – An observational study of the meaning and consequences of fibromyalgia as a dimensional disorder	18
Phenotype of diffuse cutaneous systemic sclerosis patients with positive anticentromere antibodies: A systematic literature review and meta-analysis	18
Prognostic factors in giant cell arteritis associated aortitis with PET/CT and CT angiography at diagnosis	18
Association between Kawasaki disease and subsequent autoimmune disease: National cohort study of adolescents with 12-year follow-up from birth	17
Central sensitization has major impact on quality of life in patients with axial spondyloarthritis	17

Joint and entheseal inflammation in the knee region in spondyloarthritis - reliability and responsiveness of two OMERACT whole-body MRI scores	17
Consensus-based semi-quantitative ultrasound scoring system for gout lesions: Results of an OMERACT Delphi process and web-reliability exercise	17
Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group	17
Modelling long-term outcomes for patients with systemic lupus erythematosus	17
Effects of neuromuscular control and strengthening exercises on MRI-measured thigh tissue composition and muscle properties in people with knee osteoarthritis – an exploratory secondary analysis from	17
Elderly-onset rheumatoid arthritis is a unique disease subset associated with poor overall outcomes: Response to the letter by Haroon and Ayamer	17
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group	17
Table of Contents	16
Preventive effect of beta-blockers in the development of aortic dilation in giant cell arteritis-related aortitis	16
Co-occurrence of giant cell arteritis in patients with polymyalgia rheumatica. Comment on the article by Nielsen AW, et al	16
Autoinflammatory syndromes with coexisting variants in Mediterranean FeVer and other genes: Utility of multiple gene screening and the possible impact of gene dosage	16
COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis	16
Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world da	16
Diagnostic value of different imaging features for patients with suspected gout: A network meta-analysis	16
Unveiling axial involvement in psoriatic arthritis: An ancillary analysis of the ASAS-perSpA study	16
Reply on: International, multidisciplinary Delphi consensus recommendations on non-pharmacological interventions for fibromyalgia	16
Comments on the article by Goldman et al.	15
Comparative analysis of disease outcomes: Early vs. late transition from psoriasis to psoriatic arthritis	15
Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review	15
The shrinking toe sign in gout	15
Factors associated with cardiovascular events in systemic lupus erythematosus in a monocentric cohort with up to 40 years of follow-up	15
Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets	15
Efficacy, safety, and cost-effectiveness of therapeutic drug monitoring (TDM) for TNF inhibitor therapy in rheumatic disease: A systematic review and meta-analysis	15
Comparison between rheumatoid arthritis with malignant lymphoma and other malignancies: Analysis of a National Database of Rheumatic Disease in Japan	15
Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice	15
Methotrexate use reduces mortality risk in rheumatoid arthritis: A systematic review and meta-analysis of cohort studies	15
Experience and impact of crystal pyrophosphate deposition (CPPD) from a patient and caregiver perspective: A qualitative exploration from the OMERACT CPPD working group	15
Acknowledgement of Referees	14
Defining patient perception of overall well-being and disease activity in the OMERACT Juvenile Idiopathic Arthritis (JIA) core domain set: A report from the JIA working group	14
The natural history of end-stage knee osteoarthritis: Data from the osteoarthritis initiative	14
Psychometric properties of patient-reported outcomes measurement information system (PROMIS) fixed short forms in Juvenile Myositis	14
Historical bioarcheological aspects of diffuse idiopathic skeletal hyperostosis in humans	14
Incidence and prevalence of systemic sclerosis in Sweden, 2004–2015, a register-based study	14
Self-esteem, self-concept, and body image of young people with rheumatic and musculoskeletal diseases: A systematic literature review	14
An analysis of the first relapse in giant cell arteritis using ultrasonography	14
Response to the letter entitled " Letter to the editor to Soluble CXCL16 is a prognostic biomarker associated with rapidly progressive interstitial lung disease complicated with dermatomyositis" by Ga	14
Unraveling the role of neutrophil extracellular traps in rheumatoid arthritis: From triggers to therapeutic targets	14
Minimally invasive interventional procedures for osteoarthritis and inflammatory arthritis: A systematic review and meta-analysis	14
Predicting best treatment in rheumatoid arthritis	13
Giant cell arteritis-related stroke in a large inception cohort: A comparative study	13
Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options	13
Risk of incident gout following exposure to recombinant zoster vaccine in US adults aged ≥65 years	13
How is early spondyloarthritis defined in the literature? Results from a systematic review	13
Efficacy and safety of pharmacological treatments for autoimmune disease-associated interstitial lung disease: A systematic review and network meta-analysis	13
Telemedicine in rheumatology care: A systematic review	13
Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus	13
Autoimmune rheumatic disease in Australian Aboriginal and Torres Strait Islander Peoples: What do we know?	13
A prospective observational cohort study and systematic review of 40 patients with mouth and genital ulcers with inflamed cartilage (MAGIC) syndrome	13
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials	13
Longitudinal relationships between cognitive domains and depression and anxiety symptoms in systemic lupus erythematosus	12
Impact of previous glucocorticoid therapy on diagnostic accuracy of [18F] FDG PET-CT in giant cell arteritis	12
Patient perspective on remission in rheumatoid arthritis: Validation of patient reported outcome instruments to measure absence of disease activity	12
Severity and mortality of COVID-19 in patients with systemic sclerosis: a Brazilian multicenter study	12
Age of onset of rheumatoid arthritis and radiographic changes	12
Diffuse generalized venulitis as the primary pathology of Behçet's disease: A comprehensive magnetic resonance venography study	12
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set	12
Definitions of rheumatoid arthritis flare and how they relate to patients’ perspectives: A scoping review of qualitative and quantitative evidence	12
Outcomes in ANCA-associated vasculitis patients with end-stage kidney disease on renal replacement therapy—A meta-analysis	12
Does body mass index mediate the relationship between socioeconomic position and incident osteoarthritis?	12
Immunosuppressive therapy to treat newly diagnosed primary heart involvement in patients with systemic sclerosis: An Italian cardiac magnetic resonance based study	12
Prevalence and risk factors of bronchiectasis in rheumatoid arthritis: A systematic review and meta-analysis	12
Taper versus discontinuation of tocilizumab in patients with giant cell arteritis: Real-world experience from a tertiary center	11
SAPHO syndrome: Patient stratification and the new horizon of precision medicine	11
COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study	11
SARS-CoV-2-specific T-cell responses after COVID-19 recovery in patients with rheumatic diseases on immunosuppressive therapy	11
Inflammatory myopathies associated with myelodysplastic syndromes: A French multicenter case control study and literature review	11
Racial differences in persistent glucocorticoid use patterns among medicaid beneficiaries with incident systemic lupus erythematosus	11
Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working group	11
Variations in Takayasu arteritis characteristics in a cohort of patients with different racial backgrounds	11
Clinical association of health-related quality of life and mortality in an antineutrophil cytoplasmic antibody-associated vasculitis cohort	11
Neuropathic pain in spondyloarthritis: Decoding its prevalence, risk factors, and impact on disease activity	11
Reply to: Expanding the role of mycophenolic acid in pediatric lupus nephritis: A holistic approach to extrarenal findings, side effects, and long-term outcomes	11
Sodium-glucose cotransporter 1 inhibition and gout: Mendelian randomisation study	11
Impact of biologics on health-related quality of life in patients with Ankylosing spondylitis: A systematic review and meta-analysis of randomized controlled trials	11
Correspondence on “Allopurinol adherence, persistence and patterns of use in individuals with diabetes and gout: A retrospective, population-based cohort analysis” by Weisman et al.	11
Trends in adverse pregnancy outcomes among women with systemic sclerosis in the United States	11
Association between facet joint ankylosis and functional impairment in patients with radiographic axial spondyloarthritis	11
The immune pathology of bursitis in rheumatic inflammatory diseases, degenerative conditions and mechanical stress: A systematic review	11
Macrophages–Autoimmunity–Treatment option	10
Evolution of bone lesions in adults with chronic nonbacterial osteitis (CNO): A long-term follow-up study	10

Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023	10
Immune checkpoint inhibitors and rheumatoid arthritis: All roads lead to PD-1?	10
[18F]Sodium Fluoride PET has the potential to identify active formation of calcinosis cutis in limited cutaneous systemic sclerosis	10
Distribution and trajectory of direct and indirect costs of idiopathic inflammatory myopathies	10
Adipocytokines and achievement of low disease activity in rheumatoid arthritis	10
Bone and entheseal targets for growth factors in diffuse idiopathic skeletal hyperostosis	10
Effect modification by contextual factors of urate-lowering therapy on serum urate in people with gout: A systematic review with meta-regression analysis	10
Global patterns of treat-to-serum urate target care for gout: Systematic review and meta-analysis	10
Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies	10
Patients’ perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working Group	10
Diffuse idiopathic skeletal hyperostosis (DISH) and trabecular bone score (TBS) in postmenopausal women: The Camargo cohort	10
Disease activity at conception predicts lupus flare up to two years after birth: A multicentre long term follow-up study	10
Validation studies of rheumatoid arthritis patient-reported outcome measures in populations at risk for inequity: A systematic review and analysis using the OMERACT summary of measurement properties e	10
Come rain or shine: Is weather a risk factor for musculoskeletal pain? A systematic review with meta-analysis of case-crossover studies	10
Joint and muscle inflammatory disease: A scoping review of the published evidence	10
Polygenic risk scores	10
Pregnancy outcomes in patients treated with belimumab: Report from real-world experience	10
Systematic review of imaging tests to predict the development of rheumatoid arthritis in people with unclassified arthritis	10
Corrigendum to The Glucocorticoid Toxicity Index: Measuring Change in Glucocorticoid Toxicity Over Time [Seminars in Arthritis and Rheumatism Volume 55, 152010]	9
Role of intravenous immunoglobulins in systemic sclerosis (SSc): A systematic literature review	9
Does smoking protect against developing osteoarthritis? Evidence from a genetically informed perspective	9
Brain white matter microstructural alterations in Behcet's syndrome correlate with cognitive impairment and disease severity: A diffusion tensor imaging study	9
Author Reply to Letter to the Editor	9
Navigating the path of progress: The OMERACT 2023 emerging leaders program	9
Ultra-high frequency ultrasound for digital arteries: improving the characterization of vasculopathy in systemic sclerosis	9
Corrigendum to ‘TNF-alpha inhibition for the treatment of cardiac sarcoidosis’ seminars in arthritis and rheumatism. 2020 Jun;50(3):546-552	9
Consensus-driven conceptual development of a standardized whole body-MRI scoring system for assessment of disease activity in juvenile idiopathic arthritis: MRI in JIA OMERACT working group	9
Infection case of COVID-19 in patients with rheumatic diseases receiving biologic agents in Wuhan, China: A retrospective population-based analysis from a single center	9
Reply on: a meta-analysis of clinical manifestations in asian systemic lupus erythematous: The effects of ancestry, ethnicity and gender	9
Identification of outcome domains in primary Sjögren's disease: A scoping review by the OMERACT Sjögren disease working group	9
Menopausal hormone therapy and risk of seropositive rheumatoid arthritis: A nationwide cohort study in Korea	9
Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study	9
Early-onset juvenile dermatomyositis: A tertiary referral center experience and review of the literature	9
Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group	9
An updated systematic review and meta-analysis of randomised controlled trials on the effects of urate-lowering therapy initiation during a gout flare	9
Referees	9
Why most (but perhaps not all) DMARDs work equally well	9
Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)	9
Established and novel insights to guide cancer assessment in patients with idiopathic inflammatory myopathies	8
Corrigendum to “Clinical characterization, long-term follow-up, and response to treatment of patients with syndrome of undifferentiated recurrent fever (SURF)” Seminars in Arthritis and Rheumatism 55	8
Muscle pathological features and extra-muscle involvement in idiopathic inflammatory myopathies with anti-mitochondrial antibody	8
Correspondence on “Methotrexate treatment in hand osteoarthritis refractory to usual treatments: A randomised, double-blind, placebo-controlled trial” by Ferrero et al	8
Cognitive impairment in the immune-mediated inflammatory diseases compared with age-matched controls: Systematic review and meta-regression	8
Management of disease progression after autologous hematopoietic stem cell transplantation in systemic sclerosis: Results from an international questionnaire-based study	8
Moving urate-lowering therapy in gout beyond guideline recommendations	8
Effects of secukinumab on synovitis and enthesitis in patients with psoriatic arthritis: 52-week clinical and ultrasound results from the randomised, double-blind ULTIMATE trial with open label extens	8
The phenotype of myositis patients with anti-Ku autoantibodies	8
Comment on the article by Maguire et al. pregnancy in axial spondyloarthropathy: A systematic review & meta-analysis	8
Effectiveness and tolerability of antifibrotics in rheumatoid arthritis-associated interstitial lung disease	8
Predictors of remission in people with axial spondyloarthritis: A systematic literature review	8
Anti-HMGCR myopathy: Diversity of clinical presentations in a national cohort in New Zealand	8
Response to Dr. Wolfe	8
Characteristics Of Difficult-To-Treat Psoriatic Arthritis: A Comparative Analysis	8
Serum ferritin as a significant biomarker for patients with idiopathic inflammatory myopathy-associated interstitial lung disease: A systematic review and meta-analysis	8
Developing a composite outcome tool to measure response to treatment in ANCA-associated vasculitis: A mixed methods study from OMERACT 2020	8
Assessing the quality of forced vital capacity measurement in patients with systemic sclerosis	8
Development and evaluation of shared decision-making tools in rheumatology: A scoping review	8
Missed opportunities for treatment of inflammatory arthritis and factors associated with non-treatment: An observational cohort study in United States Veterans with rheumatoid arthritis, psoriatic art	8
The impact of pain on daily activities in patients with idiopathic inflammatory myopathies: Report from the OMERACT myositis working group	8
Trends in avascular necrosis and related arthroplasties in hospitalized patients with systemic lupus erythematosus and rheumatoid arthritis	8
Post-hoc analysis of two gout remission definitions in a two-year randomized controlled trial of nurse-led versus usual gout care	8
Evaluation of a measure of end-stage knee osteoarthritis compared to total knee replacement: An observational study using multicohort data	8
Intravenous cyclophosphamide improves functional outcomes in interstitial lung disease related to idiopathic inflammatory myopathies	8
Baseline serum biomarkers of inflammation, bone turnover and adipokines predict spinal radiographic progression in ankylosing spondylitis patients on TNF inhibitor therapy	8
Association of first, second, and third-line bDMARDs and tsDMARD with drug survival among seropositive rheumatoid arthritis patients: Cohort study in A real world setting	8
One-year survival benefit of plasma exchange in idiopathic inflammatory myositis patients with progressive interstitial lung disease-a systemic review and meta-analysis	8
Clinical trial eligibility of a real-world connective tissue disease cohort: Results from the LEAP cohort	8